Using tissue mitral valves in younger patients: A word of caution. Issue 12 (30th August 2022)

• Record Type: Journal Article
• Authors: Arafat, Amr A.; AlQattan, Hussain; Zahra, Ashraf; Alghamdi, Rawan; Alghosoon, Haneen; AlGhamdi, Faisal; Alamro, Sultan; Albackr, Hanan; Ismail, Huda; Adam, Adam I.; Algarni, Khaled D.; Albacker, Turki B.
• Is Part Of: Journal of cardiac surgery. Volume 37:Issue 12(2022)
• Page Start: 4227
• Page End: 4233
• Publication Date: 2022-08-30
• Subjects: mechanical valves -- mitral valve replacement -- reoperation -- survival -- tissue valves; Heart -- Surgery -- Periodicals; 617.412005
• DOI: 10.1111/jocs.16881
• Languages: English
• ISSNs: 0886-0440

Abstract

Abstract: Background: The debate about the optimal mitral valve prosthesis continues. We aimed to compare the early and late outcomes, including stroke, bleeding, survival, and reoperation after isolated mitral valve replacement (MVR) using tissue versus mechanical valves. Methods: This retrospective cohort study included 291 patients who had isolated MVR from 2005 to 2015. Patients were grouped into the tissue valve group ( n = 140) and the mechanical valve group ( n = 151). Results: There were no differences in duration of mechanical ventilation, hospital stay, and hospital mortality between groups. Fifteen patients required cardiac rehospitalization, nine in the tissue valve group, and six in the mechanical valve group ( p = .44). Stroke occurred in nine patients, five with tissue valves, and four with mechanical valves ( p = .66). Bleeding occurred in 22 patients, seven patients with tissue valves, and 15 patients with mechanical valves ( p = .09). Freedom from reoperation was 95%, 93%, 84%, 67% at 3, 5, 7, and 10 years for tissue valve and 97%, 96%, 96%, and 93% for mechanical valves, respectively ( p ˂ .001). The median follow‐up was 84 months (Q1: Q3: 38–139). Survival at 3, 5, 7, and 10 years was 94%, 91%, 89%, 86% in tissue valves and 96%, 93%, 91%, 91% in mechanical valves, respectively ( p = .49). Conclusions: Tissue valve degeneration is still an issue even in the new generations of mitral tissue valves. The significant risk of reoperation in patients with mitral tissue valves should be considered when using those valves in younger patients. Mechanical valves remain a valid option for all age groups.